Extended trial tests Long-Term skin treatment safety
NCT ID NCT07223697
Summary
This study follows patients with moderate-to-severe atopic dermatitis (eczema) who participated in earlier trials of afimkibart. It aims to understand the long-term safety and effectiveness of continued treatment. The study will track side effects and measure improvements in skin symptoms and quality of life over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Best Skin Research LLC
RECRUITINGCamp Hill, Pennsylvania, 17011, United States
-
Centrum Medyczne Pratia Katowice I
RECRUITINGKatowice, Silesian Voivodeship, 40-081, Poland
-
Centrum Nowoczesnych Terapii "Dobry Lekarz"
RECRUITINGKrakow, 31-011, Poland
-
DermEdge
RECRUITINGMississauga, Ontario, L4Y4C5, Canada
-
Klinika Ambroziak Dermatologia
RECRUITINGWarsaw, 02-953, Poland
-
Revival Research Institute, LLC
RECRUITINGTroy, Michigan, 48084, United States
-
Uniwersytecki Szpital Kliniczny im.Fryderyka Chopina w Rzeszowie
RECRUITINGRzeszów, 35-055, Poland
Conditions
Explore the condition pages connected to this study.